Company Filing History:
Years Active: 2005-2012
Title: Moo-Hi Yoo: Innovator in Pharmaceutical Chemistry
Introduction
Moo-Hi Yoo is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of four patents. His work focuses on innovative solutions for various medical conditions, showcasing his expertise and dedication to advancing healthcare.
Latest Patents
Moo-Hi Yoo's latest patents include a three-branched polyethylene glycol-G-CSF conjugate. This invention relates to a conjugate of general formula (1) where the bonding ratio of three-branched polyethylene glycol (PEG) and G-CSF is 1:1 (mol/mol). The PEG used has an average molecular weight ranging from 200 to 45,000 daltons. Additionally, he has developed novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives, which are aimed at treating premature ejaculation. These compounds selectively inhibit serotonin reuptake, providing a new approach to managing this condition.
Career Highlights
Throughout his career, Moo-Hi Yoo has worked with notable companies such as Dong-a Pharm Co., Ltd. and Dong-a Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical products.
Collaborations
Moo-Hi Yoo has collaborated with esteemed colleagues, including Yong-duck Kim and Dong-Sung Kim. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.
Conclusion
Moo-Hi Yoo stands out as a dedicated inventor in the pharmaceutical industry, with a focus on developing innovative treatments. His contributions through patents and collaborations reflect his commitment to improving healthcare solutions.